COO vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

COO

62.4
AI Score
VS
COO Wins

XRAY

48.1
AI Score

Investment Advisor Scores

COO

62score
Recommendation
BUY

XRAY

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric COO XRAY Winner
Revenue 1.78B 3.17B COO
Net Income 27.00M 485.70M COO
Gross Margin 51.7% 67.5% COO
Net Margin 1.5% 15.3% COO
Operating Income 47.00M 403.80M COO
ROE 2.0% 5.8% COO
ROA 0.5% 3.8% COO
Total Assets 5.20B 12.67B COO
Cash 239.00M 154.70M XRAY
Debt/Equity 1.48 0.23 COO
Current Ratio 1.63 1.22 XRAY

Relative Price Performance (Last 90 Days)

COO 1M: -17.1% · 3M: -22.6% XRAY 1M: -18.8% · 3M: -25.0%

Current Technical Phase

COO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.4%), weak momentum, RSI 39

RSI (14): 39.1 · Price: $57.41

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

Fundamentals Snapshot

Metric COO XRAY
Market Cap — —
Forward P/E 12.2 5.8
Trailing P/E 19.4 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% 0.5%
Operating Margin 0.2% 0.1%
EPS 2.91 -2.69
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, COO is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.